Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
154.00
+2.00 (1.32%)
Feb 11, 2026, 1:30 PM CST
TPEX:6712 Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 210.02 | 301.68 | 336.44 | 353.57 | 641.1 | 68.88 |
Short-Term Investments | 144.5 | 636.5 | 998.6 | 915.99 | 702.6 | 346.1 |
Cash & Short-Term Investments | 354.52 | 938.18 | 1,335 | 1,270 | 1,344 | 414.98 |
Cash Growth | -44.47% | -29.73% | 5.16% | -5.52% | 223.80% | -30.15% |
Accounts Receivable | 153.62 | 193.99 | 100.63 | 84.94 | 33.66 | 15.4 |
Other Receivables | 16.14 | 7.56 | 0.46 | 0.88 | 29.6 | 2.24 |
Receivables | 169.75 | 201.54 | 101.09 | 85.82 | 63.27 | 17.63 |
Inventory | 84.17 | 80.04 | 69.09 | 88.3 | 56.77 | 35.49 |
Prepaid Expenses | 1.97 | 3.44 | 7.92 | 6.29 | 2.11 | 10.46 |
Other Current Assets | 0.04 | 0.06 | 7.73 | 5.46 | 0.92 | 0.07 |
Total Current Assets | 610.44 | 1,223 | 1,521 | 1,455 | 1,467 | 478.63 |
Property, Plant & Equipment | 79.27 | 48.58 | 64.81 | 89.84 | 125.01 | 171.24 |
Long-Term Investments | 1,034 | 796.16 | 471.31 | 376.37 | 333.27 | 112.51 |
Other Intangible Assets | 13.66 | 10.15 | 10.65 | 11.95 | 11.14 | 9.9 |
Long-Term Deferred Tax Assets | 12.02 | 10.73 | 1.71 | 30.32 | 78.2 | 80.56 |
Other Long-Term Assets | 60.46 | 47.24 | 6.57 | 9.72 | 8.22 | 5.48 |
Total Assets | 1,810 | 2,136 | 2,076 | 1,974 | 2,023 | 858.32 |
Accounts Payable | 24.59 | 25.13 | 23.33 | 29.08 | 15 | 5.04 |
Accrued Expenses | 1.69 | 2.4 | 1.96 | 3.98 | 10.49 | 3.62 |
Current Portion of Leases | 10.43 | 1.71 | 5.4 | 4.5 | 11.87 | 9.87 |
Current Income Taxes Payable | 9.77 | 68.07 | 46.76 | 10.47 | 21.04 | - |
Current Unearned Revenue | 261.97 | 194.13 | 121.65 | 89.89 | 12.22 | 4.12 |
Other Current Liabilities | 52.65 | 37.66 | 32.55 | 25.82 | 25.9 | 17.67 |
Total Current Liabilities | 361.09 | 329.09 | 231.64 | 163.74 | 96.51 | 40.32 |
Long-Term Leases | 30.98 | 1.14 | 0.5 | 13.36 | 22.55 | 33.34 |
Long-Term Deferred Tax Liabilities | 9.77 | 10.82 | - | 3.59 | 3.82 | 0.05 |
Other Long-Term Liabilities | 18.32 | 0.78 | 0.82 | 0.76 | 1.96 | 3.86 |
Total Liabilities | 420.16 | 341.82 | 232.96 | 181.45 | 124.83 | 77.56 |
Common Stock | 875.97 | 806.73 | 733.39 | 681.4 | 618.18 | 562.89 |
Additional Paid-In Capital | 509.31 | 551.72 | 785.91 | 872.22 | 1,211 | 486.55 |
Retained Earnings | 98.75 | 434.23 | 323.67 | 238.51 | 68.74 | -300.86 |
Comprehensive Income & Other | -94.39 | 1.6 | - | 0.04 | - | 32.19 |
Shareholders' Equity | 1,390 | 1,794 | 1,843 | 1,792 | 1,898 | 780.76 |
Total Liabilities & Equity | 1,810 | 2,136 | 2,076 | 1,974 | 2,023 | 858.32 |
Total Debt | 41.41 | 2.84 | 5.9 | 17.86 | 34.42 | 43.21 |
Net Cash (Debt) | 313.11 | 935.33 | 1,329 | 1,252 | 1,309 | 371.77 |
Net Cash Growth | -50.51% | -29.63% | 6.19% | -4.40% | 252.17% | -33.40% |
Net Cash Per Share | 3.55 | 10.53 | 14.72 | 13.72 | 14.38 | 4.53 |
Filing Date Shares Outstanding | 87.6 | 88.74 | 88.74 | 90.67 | 90.48 | 82.39 |
Total Common Shares Outstanding | 87.6 | 88.74 | 88.74 | 90.67 | 90.48 | 82.39 |
Working Capital | 249.36 | 894.16 | 1,289 | 1,292 | 1,370 | 438.31 |
Book Value Per Share | 15.86 | 20.22 | 20.77 | 19.77 | 20.97 | 9.48 |
Tangible Book Value | 1,376 | 1,784 | 1,832 | 1,780 | 1,887 | 770.86 |
Tangible Book Value Per Share | 15.71 | 20.11 | 20.65 | 19.63 | 20.85 | 9.36 |
Machinery | 94.1 | 93.5 | 91.2 | 85.39 | 82.64 | 104.52 |
Leasehold Improvements | 63.28 | 63.28 | 65.23 | 65.23 | 63.9 | 63.64 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.